Molecular basis of autosomal recessive chronic granulomatous disease in iran.
BACKGROUND
Chronic granulomatous disease (CGD) is a rare inherited condition resulting from mutations in the genes that encode the proteins of the NADPH oxidase enzyme in phagocytes, rendering these cells incapable of killing invading pathogens.


METHODS
Patients subtypes are determined by neutrophil functional assays and immunoblotting. Although defects in the X-chromosome-linked gp91-phox component account for the majority of CGD patients in the world, in Iran, there are many CGD patients suffering from the autosomal recessive forms of the disease. Most of these patients show impairment in the synthesis of the 47-kDa cytosolic component p47-phox of the oxidase. The second causative factor of autosomal recessive CGD is deficiency of the 22-kDa component (p22-phox) of the oxidase. Another rare form of the disease is due to mutations in the NCF2 gene encoding the 67-kDa component (p67-phox) of the oxidase.


RESULTS
Mutation analysis showed a novel homozygous splice site mutation, c.intron4+1G>T, in CYBA. A novel mutation in NCF2: a gross homozygous deletion of exon 1 and 2, causing p.Met1_Lys58 deletion in p67-phox. We also found a previously published homozygous nonsense mutation, c.196C>T, causing p.Arg66X.33 in p67-phox.


CONCLUSIONS
Our data show that CGD in Iran is predominantly due to mutations in p47-phox, while the number of mutations in p22-phox is roughly equal to that in gp91-phox. These data indicate that the genetics of CGD are ethnically variable, and this should be considered in approaching families with CGD.
Teimourian
Shahram
S
Department of Research and Development, Pasteur Institute of Iran, Tehran, Iran. teimourian@tums.ac.ir
de Boer
Martin
M
Roos
Dirk
D
D004252:DNA Mutational Analysis; D005190:Family; D005808:Genes, Recessive; D006105:Granulomatous Disease, Chronic / Q000453:epidemiology* / Q000208:ethnology / Q000235:genetics*; D006801:Humans; D007492:Iran / Q000453:epidemiology / Q000208:ethnology; D008562:Membrane Glycoproteins / Q000235:genetics*; D009154:Mutation; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000235:genetics*
D008562:Membrane Glycoproteins; C056558:CYBB protein, human; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; C086986:CYBA protein, human; C060505:neutrophil cytosolic factor 1
Eur J Clin Invest. 2009 Oct;39(10):942-51
19624736
Hum Genet. 1999 Nov;105(5):460-7
10598813
Blood. 1999 Oct 1;94(7):2505-14
10498624
Br J Haematol. 2008 Jun;141(6):848-51
18422995
J Hum Genet. 2006;51(10):887-895
16937026
Clin Immunol. 2008 Oct;129(1):103-14
18708296
Blood. 2000 Mar 15;95(6):2150-6
10706888
Int J Hematol. 2008 May;87(4):398-404
18322777
Exp Hematol. 2001 Nov;29(11):1319-25
11698128
Eur J Clin Invest. 2007 Jul;37(7):589-95
17576211
Blood. 2000 Aug 1;96(3):1106-12
10910929
J Clin Invest. 1997 Oct 15;100(8):1907-18
9329953
J Clin Immunol. 2009 Mar;29(2):215-30
18773283
Eur J Clin Invest. 2009 Apr;39(4):311-9
19292887
Hematology Am Soc Hematol Educ Program. 2005;:89-95
16304364
Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2753-7
2011585
PLoS One. 2009;4(4):e5234
19381301
Blood Cells Mol Dis. 2010 Apr 15;44(4):291-9
20167518
Hum Mutat. 2006 Dec;27(12):1218-29
16972229
J Pediatr. 1996 Jan;128(1):104-7
8551399
Histochem Cell Biol. 2004 Oct;122(4):277-91
15293055